Personalized Pathology & Cancer Therapy

Organisational unit: Research group

More filtering options
  1. 2018
  2. Tumor-associated autoantibodies as early detection markers for ovarian cancer? A prospective evaluation

    Kaaks, R. , Fortner, R. T. , Hüsing, A. , Barrdahl, M. , Hopper, M. , Johnson, T. , Tjønneland, A. , Hansen, L. , Overvad, K. , Fournier, A. , Boutron-Ruault, M. C. , Kvaskoff, M. , Dossus, L. , Johansson, M. , Boeing, H. , Trichopoulou, A. , Benetou, V. , La Vecchia, C. , Sieri, S. , Mattiello, A. & 22 others Palli, D., Tumino, R., Matullo, G., Onland-Moret, N. C., Gram, I. T., Weiderpass, E., Sánchez, M. J., Navarro Sanchez, C., Duell, E. J., Ardanaz, E., Larranaga, N., Lundin, E., Idahl, A., Karin Jirström, Björn Nodin, Travis, R. C., Riboli, E., Merritt, M., Aune, D., Terry, K., Cramer, D. W. & Anderson, K. S., 2018 Mar 8, In : International Journal of Cancer.

    Research output: Contribution to journalArticle

  3. A novel monoclonal antibody targeting carboxymethyllysine, an advanced glycation end product in atherosclerosis and pancreatic cancer

    Wendel, U., Persson, N., Risinger, C., Bengtsson, E., Björn Nodin, Lena Danielsson, Charlotte Welinder, Gunilla Nordin Fredrikson, Bo Jansson & Blixt, O., 2018 Feb 1, In : PLoS ONE. 13, 2, e0191872

    Research output: Contribution to journalArticle

  4. A translational effort to identify prognostic and predictive biomarkers in pancreatic cancer among RBM3-regulated genes

    SOFIE OLSSON HAU, Emelie Karnevi, Sebastian Lundgren, Li, B., Lynch, S., Jacob Elebro, Margareta Heby, Björn Nodin, Jakob Eberhard, Uhlen, M., Moran, B., Gallagher, W. M. & Karin Jirström, 2018 Feb 1, p. 305-305 1 p.

    Research output: Contribution to conferencePoster

  5. MMP7 modulation by short- and long-term radiotherapy in patients with rectal cancer

    Christina Stene, Polistena, A., Gaber, A., Björn Nodin, Ottochian, B., Diya Adawi, Avenia, N., Karin Jirström & Louis Banka Johnson, 2018 Jan 1, In : In Vivo. 32, 1, p. 133-138 6 p.

    Research output: Contribution to journalArticle

  6. Biomarkers in pancreatic and other periampullary cancers - some familiar and one new

    Margareta Heby, 2018, Lund: Lund University, Faculty of Medicine. 92 p.

    Research output: ThesisDoctoral Thesis (compilation)

  7. Comparison of Three Different TTF-1 Clones in Resected Primary Lung Cancer and Epithelial Pulmonary Metastases

    Halla Vidarsdottir, Tran, L., Björn Nodin, Karin Jirström, Maria Planck, Mattsson, J. S. M., Botling, J., Micke, P., Jönsson, P. & Hans Brunnström, 2018, In : American Journal of Clinical Pathology. 150, 6, p. 533-544 12 p.

    Research output: Contribution to journalArticle

  8. Tumor characteristics and prognosis in women with pregnancy-associated breast cancer

    Johansson, A. L. V., Andersson, T. M. L., Hsieh, C. C., Karin Jirström, Cnattingius, S., Fredriksson, I., Dickman, P. W. & Lambe, M., 2018, In : International Journal of Cancer. 142, 7, p. 1343-1354

    Research output: Contribution to journalArticle

  9. 2017
  10. Androgen Receptor in Stage I-II Primary Breast Cancer -Prognostic Value and Distribution in Subgroups

    Emma Niméus, Elin Folkesson, Björn Nodin, Linda Hartman & Klintman, M., 2017 Dec 1, In : Anticancer research. 37, 12, p. 6845-6853 9 p.

    Research output: Contribution to journalArticle

  11. Reaching the limits of prognostication in non-small cell lung cancer: an optimized biomarker panel fails to outperform clinical parameters

    Grinberg, M., Djureinovic, D., Hans RR Brunnström, Mattsson, J. S., Edlund, K., Hengstler, J. G., La Fleur, L., Ekman, S., Koyi, H., Branden, E., Ståhle, E., Karin Jirström, Tracy, D. K., Pontén, F., Botling, J., Rahnenführer, J. & Micke, P., 2017 Jul, In : Modern Pathology. 30, 7, p. 964-977 14 p.

    Research output: Contribution to journalArticle

  12. Clinical framework for next generation sequencing based analysis of treatment predictive mutations and multiplexed gene fusion detection in non-small cell lung cancer

    Lindquist, K. E., Anna Karlsson, Levéen, P., Hans Brunnström, Reuterswärd, C., Karolina Holm, Mats Jönsson, Annersten, K., Rosengren, F., Karin Jirström, Kosieradzki, J., Ek, L., Åke Borg, Maria Planck, Göran Jönsson & Johan Staaf, 2017 May 23, In : Oncotarget. 8, 21, p. 34796-34810 15 p.

    Research output: Contribution to journalArticle

  13. Associations of defect mismatch repair genes with prognosis and heredity in sporadic colorectal cancer

    Ghanipour, L., K. Jirström, Sundström, M., Glimelius, B. & Birgisson, H., 2017 Feb 1, In : European Journal of Surgical Oncology. 43, 2, p. 311-321

    Research output: Contribution to journalArticle

  14. High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer

    Christina Siesing, Sorbye, H., Dragomir, A., Pfeiffer, P., Qvortrup, C., Pontén, F., Karin Jirström, Glimelius, B. & Jakob Eberhard, 2017, In : PLoS ONE. 12, 8, e0182512

    Research output: Contribution to journalArticle

  15. Infiltration of γδ T cells, IL-17 + T cells and FoxP3 + T cells in human breast cancer

    Allaoui, R., Catharina Hagerling, Desmond, E., Carl Fredrik Warfvinge, Karin Jirström & Karin Leandersson, 2017, In : Cancer Biomarkers. 20, 4, p. 395-409 15 p.

    Research output: Contribution to journalArticle

  16. Prognostic role of the tumour microenvironment in esophago-gastric, pancreatic and periampullary adenocarcinoma: B cells and beyond

    Richard Fristedt, 2017, Lund: Lund University, Faculty of Medicine. 82 p.

    Research output: ThesisDoctoral Thesis (compilation)

  17. 2016
  18. Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer

    Escudero-Esparza, A., Michael Bartoschek, Chrysostomi Gialeli, Okroj, M., Owen, S., Karin Jirström, Orimo, A., Jiang, W. G., Kristian Pietras & Anna M. Blom, 2016, In : Oncotarget. 7, 47, p. 76920-76933 14 p.

    Research output: Contribution to journalArticle

  19. 2014
  20. 2013
  21. Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer.

    Karolina Boman, Anna H Larsson, Segersten, U., Kuteeva, E., Johannesson, H., Björn Nodin, Jakob Eberhard, Uhlén, M., Malmström, P-U. & Karin Jirström, 2013, In : British Journal of Cancer. 108, 11, p. 2321-2328

    Research output: Contribution to journalArticle

  22. 2012
  23. A cohort study of the prognostic and treatment predictive value of SATB2 expression in colorectal cancer

    Jakob Eberhard, Gaber, A., Wangefjord, S., Björn Nodin, Uhlén, M., Ericson Lindquist, K. & Karin Jirström, 2012 Feb 28, In : British Journal of Cancer. 106, 5, p. 931-938 8 p.

    Research output: Contribution to journalArticle

  24. Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer

    Anna H Larsson, Fridberg, M., Gaber, A., Björn Nodin, Levéen, P., Göran B Jönsson, Uhlen, M., Birgisson, H. & Karin Jirström, 2012, In : BMC Cancer. 12

    Research output: Contribution to journalArticle

  25. 2011
  26. RBM3-Regulated Genes Promote DNA Integrity and Affect Clinical Outcome in Epithelial Ovarian Cancer.

    Ehlen, O., Björn Nodin, Rexhepaj, E., Jenny Brändstedt, Uhlen, M., Maria Alvarado-Kristensson, Pontén, F., Brennan, D. J. & Karin Jirström, 2011, In : Translational Oncology. 4, 4, p. 212-221

    Research output: Contribution to journalArticle

  27. 2010
  28. 2009